Julphar secures exclusive rights to produce, market MSD medicines
09/04/2014 1:07 am EDT

share with your network:

UAE-based pharmaceutical company, Julphar has signed a five-year agreement with global healthcare firm, MSD granting Julphar exclusive rights to produce, market, distribute and sell certain MSD medicines in the region. The new partnership would enhance patients’ access to cutting-edge therapies for diabetes, asthma, allergy, pain and inflammation. Both companies will seek the relevant authorities’ prior approvals on registration and production of the products locally. The licensing agreement covers UAE, Kuwait, Bahrain, Oman, Qatar and Iraq.

About the Author

share with your network:

Share your view

© 1996-2016 Media quest FZ LLC A media and entertainment company
Middle East Main Office
[email protected]
© 2016 Dubai Business | Ameinfo . All rights Reserved.